Daniel Westaby
Impact in
-
- Prostate Cancer Treatment and Research
-
- Cancer Immunotherapy and Biomarkers
- Chemokine receptors and signaling
- Cancer Cells and Metastasis
Papers in
-
- Prostate Cancer Treatment and Research 9
-
- Cell death mechanisms and regulation 3
- Glycosylation and Glycoproteins Research 1
- Co-authors
- Adam Sharp (6 shared papers)Johann Sebastian De Bono (6 shared papers)Juan M. Jiménez‐Vacas (3 shared papers)Maria D. Fenor de la Maza (5 shared papers)Alec Paschalis (1 shared paper)Jon C. Welti (1 shared paper)Andreas S. Varkaris (1 shared paper)Steven P. Balk (1 shared paper)
- Journals
- Journal of Clinical Investigation (2 papers)Nature Communications (2 papers)European Urology Oncology (2 papers)British Journal of Cancer (1 paper)Nature (1 paper)
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
Daniel Westaby
17 papers receiving 463 citations
Peers
Comparison fields: 5 of 34
- Pulmonary and Respiratory Medicine 179
- Oncology 48
- Molecular Biology 69
- Immunology 20
- Cancer Research 6
Countries citing papers authored by Daniel Westaby
This map shows the geographic impact of Daniel Westaby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Westaby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Westaby more than expected).
Fields of papers citing papers by Daniel Westaby
This network shows the impact of papers produced by Daniel Westaby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Westaby. The network helps show where Daniel Westaby may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Westaby, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 103 | |
| 2 | 2021 | 97 | |
| 3 | 2022 | 79 | |
| 4 | 2023 | 50 | |
| 5 | 2021 | 39 | |
| 6 | 2022 | 27 | |
| 7 | 2021 | 18 | |
| 8 | 2024 | 14 | |
| 9 | 2012 | 10 | |
| 10 | 2025 | 6 | |
| 11 | 2023 | 5 | |
| 12 | 2024 | 5 | |
| 13 | 2022 | 4 | |
| 14 | 2023 | 4 | |
| 15 | 2025 | 4 | |
| 16 | 2025 | 3 | |
| 17 | 2023 | 1 | |
| 18 | 2025 | 0 | |
| 19 | 2026 | 0 |
About Daniel Westaby
Daniel Westaby is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Public Health, Environmental and Occupational Health and Nuclear Energy and Engineering, having authored 19 papers that have together received 469 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (9 papers), Cell death mechanisms and regulation (3 papers), PARP inhibition in cancer therapy (1 paper), Ectopic Pregnancy Diagnosis and Management (1 paper) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (179 citations), Oncology (48 citations), Molecular Biology (69 citations), Immunology (20 citations) and Cancer Research (6 citations). Daniel Westaby has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Adam Sharp, Johann Sebastian De Bono, Juan M. Jiménez‐Vacas, Maria D. Fenor de la Maza, Alec Paschalis, Jon C. Welti, Andreas S. Varkaris, Steven P. Balk, Paul Vincent Viscuse and Stephen Y. C. Tong. Their work appears in journals such as Journal of Clinical Investigation, Nature Communications, European Urology Oncology, British Journal of Cancer and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.